Latao, Anthony Vien D.
HRN: 26-08-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/07/2024
11/14/2024
IVTT
210mg
Q12
Phimosis, For OR
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes